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ABSTRACT 
This disclosure relates to reagents and methods useful in the 
synthesis of aryl iodines , for example , in the preparation of 
iodine labeled radiotracers . The reagents and methods pro 
vided herein may be used to access a broad range of 
compounds , including aromatic compounds , heteroaromatic 
compounds , amino acids , nucleotides , and synthetic com 
pounds . 
( 58 ) 
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RADIOIODINATED COMPOUNDS In some embodiments , a method for making a compound 
of Formula ( 1 ) : 
CROSS - REFERENCE TO RELATED 
APPLICATIONS 
5 
This application is a National Stage application under 35 
U . S . C . 8 371 of International Application No . PCT / US2015 / 
010048 , filed Jan . 2 , 2015 , which claims the benefit of U . S . 
Provisional Application No . 61 / 923 , 541 , filed Jan . 3 , 2014 . 
The disclosures of the prior applications are incorporated by " 
reference in their entirety . 
Ar > _ * I 
wherein : 
Ar is an aryl or heteroaryl ring system ; and 
1 * is a radioactive isotope of iodine ; 
includes ( a ) reacting a mixture comprising a compound M * I , 
wherein M is a counter cation , and a compound of Formula 
( 2 ) : 
FEDERALLY SPONSORED RESEARCH OR 
DEVELOPMENT 
2 
15 
Art 
This invention was made with Government support under 
Grant No . R01 EB015536 awarded by the National Insti Ar 
tutes of Health . The Government has certain rights in the 
invention . wherein : 20 Art is an aryl or heteroaryl ring system that is electron - rich 
TECHNICAL FIELD as compared to Ar ” ; 
Y is a leaving group ; and 
This disclosure relates to reagents and methods useful in Ar is as defined above ; and 
the synthesis of aryl iodides , for example , in the preparation ( b ) heating the reaction mixture from step ( a ) . 
of iodine - labeled compounds for imaging and therapy . The 25 In some embodiments , the reaction mixture in step ( a ) 
reagents and methods provided herein may be used to access further comprises a solvent . For example , the solvent can be 
a broad range of compounds , including aromatic com an aprotic solvent ( e . g . , a polar solvent , a nonpolar solvent , 
pounds , heteroaromatic compounds , amino acids , nucleo - or a mixture thereof ) . 
tides , polypeptides , and synthetic compounds . In some embodiments , the specific activity of the radio 
30 active isotope of iodine is at least about 10 mCi / mg . 
BACKGROUND Also provided herein are compounds of Formula ( 3 ) : 
Art A 
wherein : 
Art is an aryl or heteroaryl ring system that is electron - rich 
as compared to Ar ; 
Ar ’ is an aryl or heteroaryl ring system ; and 
" I is a radioactive isotope of iodine . 
Non - limiting examples of such compounds include : 
Meta - iodobenzylguanidine ( MIBG ) is a functional ana 
logue of norepinephrine ; it is taken up in tissues expressing 
large amounts of norepinephrine transporter . Such tissues 35 
include normal sympathetically innervated organs such as 
the heart and tumors that are neural crest or neuroendocrine 
in origin . MIBG was originally developed in the 1970s to 
image the adrenal medulla . The Food and Drug Adminis 
tration approved 1311 - MIBG , or iobenguane , as a tumor 40 
imaging agent in 1994 , and 1231 - MIBG , or AdreViewTM , was 
approved for tumor imaging in 2008 . Commercial formula 
tions of radioiodinated MIBG contain large amounts of 
added carrier ( 1311 - MIBG specific activity ( SA ) = 1 mCi /
umol , AdreViewTM 1231 - MIBG : SA = 1 mCi / mmol ) , because 45 
their syntheses rely on isotopic exchange with a relatively 
large mass of unlabeled “ cold ” 1271 - MIBG . “ Cold ” MIBG 
can compete with radiolabeled MIBG for binding to the 
norepinephrine transporter ( NET ) , resulting in reduced 
uptake by sympathetically innervated tissues such as the 50 
heart and neuroendocrine tumors . This is particularly a 
problem for therapeutic doses of 1311 - MIBG ; low specific 
activity MIBG has greater potential to saturate the uptake 
process in tumor cells , leading to a less potent radiotherapy . 
In addition , administration of the large mass of the biogenic 55 
amine 1271 - MIBG in a therapeutic dose of low specific 
activity 1311 - MIBG is associated with pharmacological 
effects , and must be performed by automated slow infusion 
( ~ 1 hour ) to mitigate adverse drug reactions . 
dois 
60 
SUMMARY 
Provided herein are methods of preparing substituted aryl 
and heteroaryl ring systems using diaryliodonium com 
pounds and intermediates . For example , diaryliodonium 65 
salts and diaryliodonium iodides , as provided herein , can 
undergo decomposition to prepare radiolabeled aryl iodides . Saoirs 1 * 
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- continued - continued 
1 * N? 
votar N 2 X -Br 10 
V? 
F F F 20 
* I Br 
25 
qadores 
coin , aorte 
Puola prist 
an apron 
NNN 
X -
F 
30 
35 
omnino N? L 40 
45 * I CI 
1 * L 
? 
V 
50 
Z 
- F 
X 
55 
60 N? 
Z ' N ??? ????? X - * IF F 
US 10 , 053 , 423 B2 
- continued - continued 
??? poto F 
V? arry Deals N NX 
L 
R 
* IF 
25 
wherein each Y is independently a leaving group as defined 
above ; and 
each X is independently a protecting group . 
In some embodiments , a compound of Formula ( 3 ) can be 30 
selected from the group consisting of : 
35 
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Also provided herein is a method for making a compound 
of Formula ( 1 ) 
AP _ 1 Boc 15 
wherein : 
Ar ’ is an aryl or heteroaryl ring system ; and 
* I is a radioactive isotope of iodine ; 
the method comprising heating a compound of Formula ( 3 ) : 
20 
@ 
??? 
25 25 Arl ? A 
CN CN CN Laporan Boc 
??? 
N N 
Boc 
1 
wherein : 
Art is an aryl or heteroaryl ring system that is electron - rich 
as compared to Ar ? ; and 
30 Ar is as defined above . 
This disclosure further provides a kit comprising a com 
pound of Formula ( 2 ) . In some embodiments , the kit further 
comprises a purified solvent . In some embodiments , the kit 
further comprises one or more chromatography cartridge . In 
35 some embodiments , the kit further comprises an acidic 
reagent . 
Unless otherwise defined , all technical and scientific 
terms used herein have the same meaning as commonly 
understood by one of ordinary skill in the art to which this 
40 invention belongs . Methods and materials are described 
herein for use in the present invention ; other , suitable 
methods and materials known in the art can also be used . 
The materials , methods , and examples are illustrative only 
and not intended to be limiting . All publications , patent 
45 applications , patents , sequences , database entries , and other 
references mentioned herein are incorporated by reference in 
their entirety . In case of conflict , the present specification , 
including definitions , will control . 
Other features and advantages of the invention will be 
50 apparent from the following detailed description and FIG 
URES , and from the claims . 
??? 
aorta NN Boc F DESCRIPTION OF DRAWINGS Boc A 55 FIG . 1 provides a representative 1H NMR spectra com 
paring iodination of diaryliodonium salts with fluorination , 
chlorination , and bromination . N N 
Boc DETAILED DESCRIPTION 
F F 60 60 
Definitions 
Unless defined otherwise , all technical and scientific 
terms used herein have the same meaning as is commonly 
65 understood by one of ordinary skill in the art to which this 
disclosure belongs . All patents , applications , published 
applications , and other publications are incorporated by 
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reference in their entirety . In the event that there is a plurality attached to another group . For aryl and heteroaryl groups , 
of definitions for a term herein , those in this section prevail the term “ substituted ” , unless otherwise indicated , refers to 
unless stated otherwise . any level of substitution , namely mono , di , tri , tetra , or penta 
As used herein , the singular forms “ a , " " an , ” and “ the ” substitution , where such substitution is permitted . The sub 
include plural referents unless the context clearly dictates 5 stituents are independently selected , and substitution may be 
otherwise . at any chemically accessible position . Substituents can 
The term “ Cr - valkyl ” refers to substituted or unsubstituted include , for example , an alkyl , a halogen , a hydroxyl , a 
saturated hydrocarbon groups , including straight - chain alkyl carbonyl ( such as a carboxyl , an alkoxycarbonyl , a formyl , 
and branched - chain alkyl groups that contain from x to y or an acyl ) , a thiocarbonyl ( such as a thioester , a thioacetate , 
carbons in the chain , including haloalkyl groups such as 10 or a thioformate ) , an alkoxyl , a phosphoryl , a phosphate , a 
trifluoromethyl and 2 , 2 , 2 - trifluoroethyl , etc . The terms phosphonate , a phosphinate , an amino , an amido , an ami 
“ C2 - alkenyl ” and “ C2 - alkynyl ” refer to substituted or d ine , an imine , a cyano , a nitro , an azido , a sulfhydryl , an 
unsubstituted unsaturated aliphatic groups analogous in alkylthio , a sulfate , a sulfonate , a sulfamoyl , a sulfonamido , 
length and possible substitution to the alkyls described a sulfonyl , a carbocyclyl , a heterocyclyl , an aralkyl , a 
above , but that contain at least one double or triple bond , 15 heteroaralkyl , or an aromatic or heteroaromatic moiety . It 
respectively . In some embodiments , an alkyl , alkenyl , and / or will be understood by those skilled in the art that the 
alkynyl group can be substituted with a halogen , such as moieties substituted on the hydrocarbon chain can them 
fluorine , to result in the preparation of a “ haloalkyl ” . selves be substituted , if appropriate . 
In general , the term “ aryl ” includes groups comprising a The compounds provided herein may encompass various 
ring structure having aromatic character , including rings 20 stereochemical forms and tautomers . The compounds also 
with 5 to 14 carbon atoms ( e . g . , 5 - and 6 - membered single - encompasses diastereomers as well as optical isomers , e . g . 
ring aromatic groups , such as benzene and phenyl ) . Further mixtures of enantiomers including racemic mixtures , as well 
more , the term “ aryl ” includes polycyclic aryl groups , e . g . , as individual enantiomers and diastereomers , which arise as 
tricyclic , bicyclic , such as naphthalene and anthracene . The a consequence of structural asymmetry in certain com 
aryl groups can be substituted or unsubstituted . 25 pounds . Separation of the individual isomers or selective 
The term " heteroaryl ” includes groups comprising a ring synthesis of the individual isomers is accomplished by 
structure having aromatic character , including rings with 5 application of various methods which are well known to 
to 14 atoms ( e . g . , 5 - and 6 - membered single - ring aromatic practitioners in the art . 
groups ) that have from one to four heteroatoms , for The term “ electron rich ” , as used herein , refers to an aryl 
example , pyrrole , furan , thiophene , thiazole , isothiaozole , 30 or heteroaryl ring system which is more easily oxidized as 
imidazole , triazole , tetrazole , pyrazole , oxazole , isooxazole , compared to a reference ring system . In some embodiments , 
pyridine , pyrazine , pyridazine , and pyrimidine , and the like . an electron rich ring system is more easily oxidized as 
Furthermore , the term " heteroaryl ” includes polycyclic het compared to benzene . In some embodiments , aryl or het 
eroaryl groups , e . g . , tricyclic , bicyclic , such as benzoxazole , eroaryl ring system may be substituted with one or more 
benzodioxazole , benzothiazole , benzoimidazole , benzothio - 35 substituents having a Hammett o , value of less than zero . 
phene , methylenedioxyphenyl , quinoline , isoquinoline , Methods of Preparing Substituted Aryl and Heteroaryl Ring 
napthridine , indole , benzofuran , purine , benzofuran , Systems Provided herein are methods of preparing substi 
deazapurine , indazole , or indolizine . The heteroaryl groups tuted aryl and heteroaryl ring systems using diaryliodonium 
can be substituted or unsubstituted . compounds and intermediates . For example , diaryliodonium 
The terms “ carbocycle ” , “ carbocyclyl ” , and “ cycloalkyl ” 40 salts and diaryliodonium iodides , as provided herein , can 
as used herein , refer to a 3 - to 7 - membered non - aromatic undergo decomposition to prepare radiolabeled aryl iodides . 
substituted or unsubstituted ring in which each atom of the Methods for preparing fluorinated compounds using dia 
ring is carbon . The terms " carbocycle ” , " carbocyclyl ” , and ryliodonium salts are described in WO 2013 / 184484 ; WO 
“ cycloalkyl ” also include polycyclic ring systems having 2013 / 003734 ; and WO 2010 / 048170 . 
two or more cyclic rings in which two or more carbons are 45 Fluoride is the simplest unary fluorine anion and while 
common to two adjoining rings wherein at least one of the multiple fluorine isotopes are known , only 19F is stable . The 
rings is carbocyclic , e . g . , the other cyclic rings can be radioisotope 18F has a half - life of 109 . 8 minutes and emits 
cycloalkyls , cycloalkenyls , cycloalkynyls , aryls , heteroar - positrons during radioactive decay . Structurally , and to some 
yls , and / or heterocyclyls . Carbocyclyls include cyclopropyl , extent chemically , the fluoride ion resembles the hydroxide 
cyclopentyl , cyclohexyl , cyclohexylmethyl , and 4 - methyl - 50 ion . Fluoride is the conjugate base of a relatively weak acid 
cyclohexyl . Examples of polycyclic carbocyclyls include and is therefore a hard nucleophile . Because it is the smallest 
bicyclo [ 2 . 2 . 1 ] heptanyl , norbornyl , and adamantyl . monoanion , fluoride forms salts that feature strong , highly 
The term “ heterocyclyl ” or “ heterocyclic group ” refers to ionic bonds . Moreover , fluoride forms exceptionally strong 
substituted or unsubstituted non - aromatic 3 - to 10 - mem covalent bonds to other atoms , for example the C - F bond 
bered ring structures , for example , 3 - to 7 - membered rings , 55 energy in methyl fluoride is approximately 115 kcal / mol , 
whose ring structures include one to four heteroatoms . The while the C - 1 bond in methyl iodide is approximately 58 
term " heterocyclyl ” or “ heterocyclic group ” also includes kcal / mol . The high reactivity of fluoride in diaryl iodonium 
polycyclic ring systems having two or more cyclic rings in salts results from a combination of strong ion - pairing energy 
which two or more carbons are common to two adjoining with I ( III ) cations , and the high strength of aromatic C - F 
rings wherein at least one of the rings is heterocyclic , e . g . , 60 bond in the product . The small size and high electronega 
the other cyclic rings can be cycloalkyls , cycloalkenyls , tivity of the F atom account for many of the differences 
cycloalkynyls , aryls , heteroaryls , and / or heterocyclyls . Het between fluorine and the other halogens . Ion - pairing ener 
erocyclyl groups include , for example , piperidine , pipera gies for fluoride ion are larger than those of the other 
zine , pyrrolidine , morpholine , lactones , lactams , and the halogens , and these ion - pairing interactions are the key 
like . 65 factors that determine the kinetics and thermodynamics of 
The term " substituted ” means that an atom or group of reactions involving fluoride transfer in solution . ( Ion pairing 
atoms formally replaces hydrogen as a “ substituent ” of “ weakly - coordinated ” fluoride salts H . Sun , B . Wang , and 
US 10 , 053 , 423 B2 
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1 25 
S . G . DiMagno , Chemistry Today , 2008 , 26 , 4 - 6 ; Room the radioactive isotope of iodine is 1231 . In some embodi 
Temperature Nucleophilic Aromatic Fluorination : Experi ments , the radioactive isotope of iodine is 1241 . In some 
mental and Theoretical Studies , H . Sun and S . G . DiMagno , embodiments , the radioactive isotope of iodine is 1251 . In 
Angew . Chem . Int . Ed . 2006 , 45 , 2720 - 2725 . Also Angew . some embodiments , the radioactive isotope of iodine is 13 ' 1 . 
Chem . 2006 , 118 , 2786 - 2791 ) . The high electronegativity of 5 In some embodiments , the specific activity of the radio 
fluoride also means that it typically does not act as a active isotope of iodine is at least about 10 mCi / mg . In some 
reducing agent as the standard reduction potential of fluoride embodiments , the specific activity of the radioisotope of 
( - 2 . 87 V ) is beyond the range of almost all chemical iodine is greater than about 1 Ci / mg . In some embodiments , 
oxidants ( F , is an extraordinarily potent oxidant ) . the specific activity is greater than about 10 Ci / mg . 
Iodide is one of the largest monatomic anions . It is 10 Y can be any suitable leaving group . In some embodi ments , Y is a weakly coordinating anion ( i . e . , an anion that assigned a radius of around 206 picometers . For comparison , coordinates only weakly with iodine ) . For example , Y can be the lighter halides are considerably smaller : bromide ( 196 
pm ) , chloride ( 181 pm ) , and fluoride ( 133 pm ) . In part the conjugate base of a strong acid , for example , any anion for which the pKa of the conjugate acid ( H — Y ) is less than because of its size , iodide forms relatively weak bonds with about 1 . For example , Y can be triflate , mesylate , nonaflate , most elements . It is the conjugate base of a strong acid and 15 hexaflate , toluene sulfonate ( tosylate ) , nitrophenyl sulfonate is therefore likely to bind much more poorly than other ( nosylate ) , bromophenyl sulfonate ( brosylate ) , perfluoro 
nucleophiles , including the other halogens ( see , e . g . , Chun , 
J - H and Pike , V . W . Eur . J . Org . Chem . ( 2012 ) 4541 - 4547 ) . alkyl sulfonate ( e . g . , perfluoro C2 - 10 alkyl sulfonate ) , tetra phenylborate , hexafluorophosphate , trifluoroacetate , per Iodine , however is a much stronger reducing agent than the fluoroalkylcarboxylate , tetrafluoroborate , perchlorate , other halogens and is therefore more prone to form iodo and 20 hexafluorostibate , hexachlorostibate , and chloride . In some diaryliodo radicals . 
Provided herein is a method for making a compound of embodiments , a slightly more basic leaving group such as acetate , triflate , or benzoate may be used . Formula ( 1 ) : The counter ion M can be any suitable cation for iodide . 
Ar > _ * I The choice of M , is readily within the knowledge of one of 
ordinary skill in the art . For example , M can be chosen from wherein : an alkali metal , alkaline earth metal and transition metal Ar ’ is an aryl or heteroaryl ring system ; and 
I * is a radioactive isotope of iodine ; salts such as , for example , calcium , magnesium , potassium , sodium and zinc salts . Metal cations may also be complexed the method comprising : ( a ) reacting a mixture comprising a compound M * I , wherein 30 to cryptands or crown ethers to enhance their solubility and to labilize the iodide moiety . M can also include organic salts M is a counter cation , and a compound of Formula ( 2 ) : made from quaternized amines derived from , for example , 
N , N ' dibenzylethylenediamine , chloroprocaine , choline , 
diethanolamine , ethylenediamine , meglumine ( N - methylg 
lucamine ) and procaine . In some embodiments , M can be a 35 lithium , sodium , potassium , or cesium with cryptands or 
crown ethers , a tetrasubstituted ammonium cation , or phos 
phonium cation . A variety of iodide sources can be used in 
the preparation of the fluorinated aryl and heteroaryl com 
wherein : pounds as provided herein , including but not limited to Lil , Arl is an aryl or heteroaryl ring system that is electron - rich Nal , KI , CsI , tetrabutylammonium iodide , and tetramethyl 
as compared to Ar ” ; ammonium iodide . In some embodiments , the iodide salt 
Y is a leaving group ; and will be obtained in aqueous solution . In some embodiments , 
Ar ’ is as defined above ; and the source radioiodide salt will contain additives , such as ( b ) heating the reaction mixture from step ( a ) . sodium hydroxide . In certain instances the choice of iodide 
Further provided herein is a method for making a com - " source will depend on the functionality present on the 
pound of Formula ( 1 ) compound of Formula ( 2 ) . 
In some embodiments , Art — H is more easily oxidized Ap2 _ * I than benzene . For example , Art can be substituted with at 
wherein : least one substituent having a Hammett o , value of less than 
Ar ’ is an aryl or heteroaryl ring system ; and zero ( see , for example , “ A survey of Hammett substituent 
* I is a radioactive isotope of iodine ; constants and resonance and field parameters " , Corwin . 
the method comprising heating a compound of Formula ( 3 ) : Hansch , A . Leo , R . W . Taft Chem . Rev . , 1991 , 91 ( 2 ) , pp 
165 - 195 ) . In some embodiments , the substituent is selected 
from the group consisting of : ( C - C10 ) alkyl , ( C , - C10 ) 
haloalkyl , ( C2 - C10 ) alkenyl , ( C2 - C10 ) alkynyl , O - ( C1 
C10 ) alkyl , - C ( O ) _ 0 ( C2 - C10 ) alkyl , aryl , and heteroaryl . 
Examples of Art include : 
2 
Art 
AR 
45 
( 3 ) S5 
* 1 
Arl AR 
60 R R 2 R wherein : 
Art is an aryl or heteroaryl ring system that is electron - rich 
as compared to Ar ? ; and 
Ar ’ is as defined above . 
In any of the above embodiments , the radioactive isotope 65 
of iodine can be selected from the group consisting of : 1231 , 
1241 , 1251 , 1311 , and mixtures thereof . In some embodiments , 
nu 
R4 RS 
14 
- continued 
F trois F 
- 
Net 
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13 
wherein : 
R ' , R2 , R3 , R4 , and RS are independently selected from the 
group consisting of : H , ( C , - C10 ) alkyl , ( C , - C10 ) ha 
loalkyl , ( C2 - C10 ) alkenyl , ( C2 - C10 ) alkynyl , 0 ( C4 
C10 ) alkyl , C ( O ) - 0 ( C1 - C10 ) alkyl , aryl , and het - 5 
eroaryl , or two or more of R1 , R2 , R3 , R4 , and Rs come 
together to form a fused aryl or heteroaryl ring system . 
In some embodiments , Art can be substituted with a solid 
support . A " solid support ” may be any suitable solid - phase 
support which is insoluble in any solvents to be used in the 
process but which can be covalently bound ( e . g . , directly to 
Arl or via a linker ) . Examples of suitable solid supports 
include polymers such as polystyrene ( which may be block 
grafted , for example with polyethylene glycol ) , polyacryl 
amide , or polypropylene or glass or silicon coated with such 
a polymer . The solid support may be in the form of small 
discrete particles such as beads or pins , or as a coating on the 
inner surface of a reaction vessel , for example a cartridge or 
a microfabricated vessel . See , for example , U . S . Patent 
Application No . 2007 / 0092441 . 
In some embodiments , the solid support is covalently 
bound to Arl through the use of a linker . A “ linker ” can be 
any suitable organic group which serves to space the Ar ! 
from the solid support structure so as to maximize reactivity . 
For example , a linker can include a C1 - 20 alkyl or a C1 - 20 
alkoxy , attached to the solid support , for example , via an 
amide ether or a sulphonamide bond for ease of synthesis . 
The linker may also be a polyethylene glycol ( PEG ) linker . 
Examples of such linkers are well known to those skilled in 
the art of solid - phase chemistry . 
The methods described herein can be used with a variety 
of aryl and heteroaryl ring systems . As is well understood by 
one of skill in the art , to carry out efficient nucleophilic 
substitution of the aryl and heteroaryl ring systems described 
herein , it is necessary that Ar ? be more easily oxidized ( i . e . , 
more electron rich ) than Ar . Within that boundary , however , 
the Ar ? moiety can be any aryl or heteroaryl ring system in 
which substitution by a radioisotope of iodine is desired . For 
example , Ar ” can be a phenylalanine , tyrosine , typtophan , or 
histidine derivative , and an estradiol derivative . 40 Br In some embodiments , Ar can be chosen from : 
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Protecting groups can be a temporary substituent which 
protects a potentially reactive functional group from unde 
sired chemical transformations . The choice of the particular 
protecting group employed is well within the skill of one of 
ordinary skill in the art . A number of considerations can 
determine the choice of protecting group including , but not 
limited to , the functional group being protected , other func 
65 tionality present in the molecule , reaction conditions at each 
step of the synthetic sequence , other protecting groups 
present in the molecule , functional group tolerance to con 
??? 
Br 
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ditions required to remove the protecting group , and reaction In further embodiments , the nonpolar solution of the 
conditions for the thermal decomposition of the compounds reaction mixture of M * I and a compound of Formula ( 2 ) can 
provided herein . The field of protecting group chemistry has be filtered prior to heating , the nonpolar solvent can be 
been reviewed ( Greene , T . W . ; Wuts , P . G . M . Protective removed ( e . g . , by evaporation ) , and the heating of the 
Groups in Organic Synthesis , 2 . sup . nd ed . ; Wiley : New 5 sample can be performed in a different solvent . 
York , 1991 ) . In some embodiments , contaminant salts are removed 
For example , protecting groups for amines include , but from the solution of the reaction mixture of M * I and a 
are not limited to , t - butoxycarbonyl ( BOC ) , benzyloxycar compound of Formula ( 2 ) in the polar or nonpolar solution 
bonyl ( Cbz ) , 2 , 2 , 2 - trichloroethoxycarbonyl ( Troc ) , 2 - ( 4 - tri by chromatography . For example , the contaminant salts can 
fluoromethylphenylsulfonyl ) ethoxycarbonyl ( Tsc ) , 1 - ada - be removed by size exclusion , gel filtration , reverse phase , 
mantyloxycarbonyl ( Adoc ) , 2 - adamantylcarbonyl ( 2 - Adoc ) , or other chromatographic method prior to heating . 
2 , 4 - dimethylpent - 3 - yloxycarbonyl ( Doc ) , cyclohexyloxy - Anonpolar solvent can be any solvent having a dielectric 
carbonyl ( Hoc ) , 1 , 1 - dimethyl - 2 , 2 , 2 - trichloroethoxycarbonyl constant of less than about 10 . Examples of nonpolar sol 
( TcBOC ) , vinyl , 2 - chloroethyl , 2 - phenylsulfonylethyl , allyl , 16 vents include benzene , toluene , o - xylene , m - xylene , p - xy 
benzyl , 2 - nitrobenzyl , 4 - nitrobenzyl , diphenyl - 4 - pyridylm lene , ethyl benzene , carbon tetrachloride , hexane , cyclo 
ethyl , N ' , N ' - dimethylhydrazinyl , methoxymethyl , t - bu hexane , fluorobenzene , chlorobenzene , nitrobenzene , and 
toxymethyl ( Bum ) , benzyloxymethyl ( BOM ) , or 2 - tetrahy mixtures thereof . In some embodiments , the aprotic solvent 
dropranyl ( THP ) . comprises toluene . 
Carboxylic acids can be protected as their alkyl , allyl , or 20 A polar solvent is a solvent having a dielectric constant greater than about 10 . Examples of polar solvents include benzyl esters , among other groups . 
acetonitrile , acetone , dichloromethane , ethyl acetate , tetra Alcohols can be protected as esters , such as acetyl , hydrofuran , dimethylformamide , 1 , 2 - difluorobenzene , ben benzoyl , or pivaloyl , or as ethers . Examples of ether pro zotrifluoride , dimethoxyethane , diglyme , diethyl ether , dibu tecting groups for alcohols include , but are not limited to tyl ether , and mixtures thereof . In some embodiments , the alkyl , allyl , benzyl , methoxymethyl ( MOM ) , t - butoxym - 25 aprotic solvent comprises acetonitrile . ethyl , tetrahydropyranyl ( THP ) , p - methoxybenzyle ( PMB ) , In some embodiments , the aprotic solvent is a mixture of trityl , and methoxyethoxymethyl ( MEM ) . 
In some embodiments , the protecting groups are acid a polar and nonpolar solvent . Without being bound by 
labile protecting groups . theory , it is believed that the reaction proceeds faster in the 
In some embodiments , the protecting groups are base 30 presence of a nonpolar solvent while a polar solvent helps to 
labile protecting groups . maintain the solubility of the various reactants . In some 
In some embodiments , the protecting group are acid labile embodiments , the aprotic solvent is a mixture of a polar and 
protecting groups , which can be easily be removed at the end nonpolar solvent wherein the mixture is composed of about 
of all synthetic steps under acidic deprotection conditions . 95 % polar solvent and about 5 % nonpolar solvent , about 
The methods provided herein can be performed in the 35 90 % polar solvent and about 10 % nonpolar solvent ; about presence of a solvent ( e . g . , an aprotic solvent ) . For example , 85 % polar solvent and about 15 % nonpolar solvent ; about the reaction can be performed in the presence of a polar 80 % polar solvent and about 20 % nonpolar solvent ; about solvent , a nonpolar solvent , or a mixture thereof . In some 75 % polar solvent and about 25 % nonpolar solvent ; about embodiments , the reaction mixture in step ( a ) further com 
prises an aprotic solvent as described herein . In some 40 70 % polar solvent and about 30 % nonpolar solvent ; about 
embodiments , the solvent comprises a polar solvent . In some 65 % polar solvent and about 35 % nonpolar solvent ; about 
embodiments , the solvent is removed from the reaction 60 % polar solvent and about 40 % nonpolar solvent ; about 
mixture prior to step ( b ) . In some embodiments , the reaction 55 % polar solvent and about 45 % nonpolar solvent ; about 
mixture in step ( b ) further comprises a solvent ( e . g . , an 50 % polar solvent and about 50 % nonpolar solvent ; about 
aprotic solvent ) . In some embodiments , the solvent com - 45 45 % polar solvent and about 55 % nonpolar solvent ; about 
prises a nonpolar solvent . 60 % polar solvent and about 40 % nonpolar solvent ; about 
In some embodiments , the method can include reacting in 550 55 % polar solvent and about 45 % nonpolar solvent ; about a polar solvent a compound M * I , wherein M is a counter ion , 45 % polar solvent and about 55 % nonpolar solvent ; about and a compound of Formula ( 2 ) . The polar solvent can be 
removed from the reaction mixture following completion of 50 40 % polar solvent and about 60 % nonpolar solvent ; about 
the reaction . The remaining remaining mixture can then be 35 % polar solvent and about 65 % nonpolar solvent ; about 
combined with a nonpolar solvent and heated to produce a 30 % polar solvent and about 10 % nonpolar solvent ; about 
compound of Formula ( 1 ) . 25 % polar solvent and about 75 % nonpolar solvent ; about 
In some embodiments , the method can include heating a 20 % polar solvent and about 80 % nonpolar solvent ; about 
mixture comprising a nonpolar solvent , a compound M * I , 55 15 % polar solvent and about 85 % nonpolar solvent ; about 
and a compound of Formula ( 2 ) . For example , the method 10 % polar solvent and about 90 % nonpolar solvent ; or about 
can include heating a mixture comprising a nonpolar and a 5 % polar solvent and about 95 % nonpolar solvent . In some polar solvent , a compound M * I , and a compound of Formula embodiments , the aprotic solvent is a mixture having about ( 2 ) . In some such embodiments , the nonpolar solvent 5 to about 20 % polar solvent and about 80 % to about 95 % includes toluene and the polar solvent includes acetonitrile . 60 
In some embodiments , the nonpolar solution of the reac nonpolar solvent . For example , the mixture can include 
tion mixture of M * I and a compound of Formula ( 2 ) can be about 10 % polar solvent and about 90 % nonpolar solvent . In 
filtered prior to heating . The filtration step can remove any some embodiments , the polar solvent is acetonitrile and the 
insoluble material ( e . g . , insoluble salts ) that remain in the nonpolar solvent is toluene . 
reaction mixture . In some embodiments , the solvent can be 65 Heating can be accomplished by conventional means 
removed from the filtrate prior to heating ( i . e . , the residue ( e . g . , heating bath , oven , heat gun , hot plate , Bunsen burner , 
can be heated neat ) . heating mantle , and the like ) , by the use of a microwave , or 
US 10 , 053 , 423 B2 
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F 
by flash pyrolysis . Typically , the reaction mixture is heated 
at a temperature ranging from about 25° C . to about 250° C . 
( e . g . , between about 80° C . to about 200° C . , 100° C . to 
about 200° C . , about 120° C . to about 170° C . , about 120° 
C . to about 160° C . , about 120° C . to about 150° C . , and 5 
about 130° C . to about 150° C . ) . In some embodiments , the 
reaction mixture is heated to about 140° C . Heating can 
occur for any time necessary to complete the reaction . For 
example , heating can occur for from about 1 second to about 
12 hours ( e . g . , about 2 seconds , about 5 seconds , about 10 10 
seconds , about 30 seconds , about 1 minute , about 90 sec 
onds , about 2 minutes , about 3 minutes , about 5 minutes , 
about 8 minutes , about 10 minutes , about 12 minutes , about 
15 minutes , about 20 minutes , about 25 minutes , about 30 15 
minutes , about 1 hour , about 2 hours , about 3 hours , about 
4 hours , about 6 hours , about 8 hours , about 10 hours , and 
about 12 hours ) . In some embodiments , heating can occur 
for from about 1 second to about 2 hours . 
In some embodiments , a compound of Formula ( 2 ) is 20 
selected from the group consisting of : 
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each X is independently a protecting group . 
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55 For example , a compound of Formula ( 1 ) can be selected 
from the group consisting of : 
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In some embodiments , a compound of Formula ( 3 ) is 
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N – Boc 
the diaryliodonium compound . The particular method 
employed for preparing the diaryliodonium compounds will 
be readily apparent to a person of ordinary skill in the art . 
For example , the compounds can be made using the follow 
5 ing generic reactions as shown in Scheme 2 . NN de Boc Scheme 2 . obra * 10 Arl — + Ap — H Ar — 1 — Ar + HY conditions 
15 
o sw v .
aorta 
??? Ar — H + Ar — ? 
I 
Art — 1 — Ar + HY 
conditions 
Z 
20 Boc Ar — I + Ar — M – 
conditions Ar — 1 — Ar + MY 
Boc Boc 25 
Art - M + Ar — I Ar — 1 — Ar + MY 
conditions 
' N 
Boc 
F 
* 
??? 
For compounds that bear sensitive functionality on the 
30 accepting group , organometallic reagents that feature more 
covalent ( more stable ) C - M bonds can be used . For example , 
organometallic compounds including tin , boron , and zinc . If 
there is no functional group incompatibility , more basic 
organometallic reagents ( organolithium , Grignard , etc . ) can 
35 be used to prepare the diaryliodonium salts . 
Persons skilled in the art will be aware of variations of , 
and alternatives to , the processes described which allow the 
compounds defined herein to be obtained . 
It will also be appreciated by persons skilled in the art 
40 that , within certain of the processes described , the order of 
the synthetic steps employed may be varied and will depend 
N N inter alia on factors such as the nature of other functional 
groups present in a particular substrate , the availability of 
Boc key intermediates , and the protecting group strategy ( if any ) 
45 to be adopted . Clearly , such factors will also influence the 
choice of reagent for use in the said synthetic steps . 
The skilled person will appreciate that the diaryliodonium 
Compounds compounds described could be made by methods other than 
Diaryliodonium compounds , for example , compounds of those herein described , by adaptation of the methods herein 
Formulas ( 2 ) and ( 3 ) , are further provided herein . The 50 described and / or adaptation of methods known in the art , for 
diaryliodonium compounds of Formulas ( 2 ) and ( 3 ) can be example US 2007 / 0092441 , or using standard textbooks 
prepared from commercially available starting materials such as “ Comprehensive Organic Transformations — A 
using various methods known to those of ordinary skill in Guide to Functional Group Transformations " , R C Larock , 
the art . The method used for synthesizing the compounds Wiley - VCH ( 1999 or later editions ) and Science of Synthe 
will depend on the electronics and functionality present in of 55 sis , Volume 31a , 2007 ( Houben - Weyl , Thieme ) 
Ar? . Potentially reactive functional groups present in Ar can As exemplified in the examples below , certain diaryliodo 
be masked using a protecting group prior to the synthesis of nium iodides can be prepared as shown in Scheme 1 . 
arra 
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It is to be understood that the synthetic transformation Example 2 : Preparation of [ 3 - ( ( 2 , 5 - dioxo - 2 , 5 - di 
methods mentioned herein are exemplary only and they may hydro - 1H - pyrrol - 1 - yl ) methyl ) phenyl ] - ( 4 ' - methoxy 
be carried out in various different sequences in order that the phenyl ) iodonium triflate desired compounds can be efficiently assembled . The skilled 
chemist will exercise his judgment and skill as to the most 13 
efficient sequence of reactions for synthesis of a given target 
compound . 
Kit 
Also provided herein are kits . Typically , a kit is used to 20 
prepare a compound of Formula ( 1 ) as provided herein prior OTE 
to administration . In some embodiments , the kit comprises 
a compound of Formula ( 2 ) . In some embodiments , the kit In a Nz charged glovebox , a solution of TMSOAC ( 10 . 4 
can further include a purified solvent ( e . g . , a substantially mmol , 1 . 37 g , 2 . 6 eq . ) in 50 mL of dry CH3CN was added 
waterless solvent ) . In some embodiments , the kit can further 25 dropwise to a solution of Selectfluor ( 5 . 2 mmol , 1 . 84 g , 
include one to four chromatography cartridges ( e . g . , to 1 . 3 eq . ) in 50 mL of dry CH3CN . The resulting colorless 
purify the final radioiodinated compound prior to adminis - mixture was then added dropwise to a solution of N - ( 3 
tration ) . In some embodiments , the kit can further include an iodobenzyl ) maleimide ( 4 mmol , 1 . 25 g , 1 . 0 eq . ) in dry 
acidic reagent ( e . g . , to remove any protecting groups incor - CH2CN ( 150 mL ) . After the resulting solution was stirred at 
porated into the compound of Formula ( 2 ) ) . In certain 30 room temperature for one day , potassium 4 - methoxyphenyl 
embodiments , a kit can include one or more delivery sys - trifluoroborate ( 856 mg , 4 mmol , 1 . 0 equiv . ) was added . 
tems , e . g . , for delivering or administering a compound of Immediately thereafter , a solution of TMSOTf ( 764 mg , 3 . 4 
Formula ( I ) as provided herein , and directions for use of the mmol , 0 . 8 eq . ) in 50 . 0 mL of dry CH3CN was added in a 
kit ( e . g . , instructions for preparing the compound of For dropwise fashion , and the mixture was allowed to stand at 
mula ( 1 ) ) . room temperature for 30 min . The acetonitrile was removed 
under reduced pressure . Deionized water ( 200 mL ) was 
EXAMPLES added to the remaining solid and the mixture was extracted ( 3x50 mL ) with CH , C12 . The combined organic layers were 
The invention is further described in the following 40 washed with water ( 50 mL ) and the obtained water layer was 
examples , which do not limit the scope of the invention extracted ( 50 mLx2 ) with CH CH2 again . The combined 
described in the claims . organic extracts were dried over sodium sulfate , filtered , and 
the solvent was removed by rotary evaporation . This com 
pound was dissolved in 1 mL acetonitrile / water ( 9 : 1 by Example 1 : Preparation of volume ) solution and slowly passed down an Amberlite N - ( 3 - iodobenzyl ) maleimide IRA - 400 ion exchange column ( triflate counterion ) . After 
removal of the solvents under reduced pressure , the purified 
iodonium triflate product ( 1 . 06 g , 47 % ) was obtained by 
washing the colorless residue with EtoAc to remove any 
organic impurities . ' H NMR ( CD2CN , 400 MHz ) : 8 7 . 98 ( d , 
J = 8 . 4 Hz , 2H ) , 7 . 90 ( d , J = 8 . 4 Hz , 2H ) , 7 . 86 ( s , 1H ) , 7 . 58 ( d , 
J = 7 . 2 Hz , 1H ) , 7 . 47 ( t , J = 8 . 0 Hz , 1H ) , 7 . 07 ( d , J = 8 . 4 Hz , 
2H ) , 6 . 83 ( s , 2H ) , 4 . 64 ( s , 2H ) , 3 . 85 ( s , 3H ) ; 19F NMR ( CD2CN , 376 MHz ) : 8 – 79 . 3 ( s , 3F ) . 
55 
Diisopropyl azodicarboxylate ( DIAD ) ( 12 mmol , 2 . 43 g , Example 3 : Preparation of [ 4 - ( ( 2 , 5 - dioxo - 2 , 5 - di 
2 . 40 mL , 1 . 2 eq . ) was added over the course of one hour to hydro - 1H - pyrrol - 1 - yl ) methyl ) phenyl ] - ( 4 ' - methoxy 
a solution of 3 - iodobenzyl alcohol ( 10 mmol , 2 . 34 g , 1 . 0 phenyl ) iodonium triflate 
eq . ) , PPhz ( 11 mmol , 2 . 88 g , 1 . 1 eq . ) , and maleimide ( 11 
mmol , 1 . 07 g , 1 . 1 eq . ) in 100 mL of THF . After the resulting 60 OTE 
yellow solution was stirred overnight , the solvent was 
removed and the residue was purified by column chroma 
tography on silica gel ( hexanes : ethyl acetate = 1 : 5 , R = 0 . 3 ) 
and washed with hexane to obtain 1 . 79 g ( 57 % ) of product 
as a white solid . ' H NMR ( CD CN , 400 MHz ) : 8 7 . 64 ( d , 65 
J = 1 . 6 Hz , 1H ) , 7 . 63 ( d , J = 9 . 6 Hz , 1H ) , 7 . 27 ( d , J = 7 . 6 Hz , 
1H ) , 7 . 09 ( t , J = 7 . 6 Hz , 1H ) , 6 . 78 ( s , 6H ) , 4 . 56 ( s , 2H ) . 
50 
55 
van 
37 
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This compound was prepared from N - ( 4 - iodobenzyl ) ma - ( CD2CN , 400 MHz ) : 8 8 . 04 ( d , J = 8 . 4 Hz , 2H ) , 7 . 67 ( d , J = 8 . 4 
leimide using the same procedure that is described in Hz , 2H ) , 7 . 42 ( d , J = 8 . 4 Hz , 2H ) , 7 . 04 ( d , J = 8 . 4 Hz , 2H ) , 4 . 05 
example 2 . A ( 3 mmol scale reaction yielded 910 mg of ( s , 2H ) , 2 . 83 ( s , 4H ) . 
product , ( 53 % ) . ' H NMR ( CD2CN , 400 MHz ) : 8 7 . 99 ( d , 
J = 9 . 2 Hz , 2H ) , 7 . 97 ( d , J = 8 . 8 Hz , 2H ) , 7 . 40 ( d , J = 8 . 4 Hz , 5 Example 6 : Preparation of [ 4 - ( 4 - ( ( ( 2 , 5 - dioxopyrro 
2H ) , 7 . 05 ( d , J = 9 . 2 Hz , 2H ) , 6 . 80 ( s , 2H ) , 4 . 67 ( s , 2H ) , 3 . 84 lidin - 1 - yl ) oxy ) carbonyl ) benzyl ) phenyl ] - 1 - ( 4 ' 
( s , 3H ) ; 1°F NMR ( CD3CN , 376 MHz ) : 0 - 79 . 3 ( s , 3F ) . methoxyphenyl ) iodonium triflate 
Example 4 : Preparation of 4 - ( 4 - iodobenzyl ) benzoic 
acid 10 
OTf 
COH 
In a N , charged glovebox , a solution of TMSOAC ( 3 . 90 
In a 500 mL round bottom flask that was shielded from mmol , 516 mg , 2 . 6 eq . ) in 20 mL of dry CH3CN was added 
light with aluminum foil , a stirred solution of 4 - benzylben dropwise to a solution of SelectfluorTM ( 1 . 95 mmol , 691 mg , 
zoic acid ( 1 . 06 g , 5 mmol , 1 . 0 eq . ) , NIS ( 1 . 24 g , 5 . 5 mmol , 1 . 3 eq . ) in 20 mL of dry CH3CN . The resulting colorless 
1 . 1 eq . ) and Yb ( OTf ) 3 ( 310 mg , 0 . 50 mmol , 0 . 1 eq . ) in mixture was then added slowly ( dropwise ) to a solution of 2 , 5 - dioxopyrrolidin - 1 - yl 4 - ( 4 - iodobenzyl benzoate ( 1 . 5 CH2CN ( 100 mL ) was heated to 75 - 80° C . for 12 hours . 
After 12 h , a supplementary portion of NIS ( 0 . 56 g , 2 . 5 25 mmol , 653 mg , 1 . 0 eq . ) in 40 mL of dry CH3CN . The 
mixture was stirred at room temperature for 2 days before mmol , 0 . 5 eq . ) was added to drive the reaction to comple potassium 4 - methoxyphenyltrifluoroborate ( 320 mg , 1 . 5 tion . After an additional hour , the solvent was removed by mmol , 1 . 0 equiv . ) was added . Immediately thereafter , a 
rotary evaporation , and the residue was partitioned between solution of TMSOTF ( 267 mg , 1 . 2 mmol , 0 . 8 eq . ) in 20 . 0 mL 
water and ethyl acetate . The mixture was extracted ( 3x50 of dry CH CN was added slowly ( dropwise ) , and the mix 
mL ) with ethyl acetate and the combined organic extracts 30 ture was allowed to stand at room temperature for 30 
were washed with water , dried over MgSO4 , and filtered . minutes . The acetonitrile was removed by rotary evapora 
The solvent was removed by rotary evaporation , and the tion , 100 mL of deionized water was added , and the mixture 
residue was purified by flash chromatography on silica gel was extracted ( 3x30 mL ) with CH C12 . The combined 
( hexanes : ethyl acetate = 1 : 1 , Rf = 0 . 2 ) to give 4 - ( 4 - iodoben organic extracts were washed with water ( 50 mL ) and the 
zyl ) benzoic acid as a white solid ( 1 . 28 g , 76 % ) . ' H NMR aqueous layer was extracted ( 2x50 mL ) with CH2Cl2 again . ( CD , CN , 400 MHz ) : 87 . 91 ( d , J = 8 . 0 Hz , 2H ) , 7 . 65 ( d , J = 8 . 4 The combined organic extracts were dried over sodium 
Hz , 2H ) , 7 . 31 ( d , J = 8 . 4 Hz , 2H ) , 7 . 03 ( d , J = 8 . 4 Hz , 2H ) , 3 . 99 sulfate , filtered , and concentrated in vacuo . The residue was 
( s , 2H ) . washed with methy t - butyl ether ( MTBE ) . This compound 
was dissolved in 1 mL acetonitrile / water ( 9 : 1 by volume ) 
Example 5 : Preparation of 2 , 5 - dioxopyrrolidin - 1 - yl solution and slowly passed down an Amberlite IRA - 400 ion 
4 - ( 4 - iodobenzyl ) benzoate exchange column ( triflate counterion ) . After removal of the 
solvents under reduced pressure , the purified iodonium 
triflate product was obtained by washing the colorless resi 
due with pentane to remove any organic impurities ( 540 mg , 45 52 % ) . ' H NMR ( CD3CN , 400 MHz ) : 8 8 . 05 ( d , J = 8 . 0 Hz , 
2H ) , 7 . 99 ( d , J = 9 . 2 Hz , 2H ) , 7 . 95 ( d , J = 8 . 4 Hz , 2H ) , 7 . 42 ( d , 
J = 8 . 4 Hz , 2H ) , 7 . 38 ( d , J = 8 . 4 Hz , 2H ) , 7 . 05 ( d , J = 9 . 2 Hz , 
2H ) , 4 . 16 ( s , 2H ) , 3 . 83 ( s , 3H ) , 2 . 84 ( s , 4H ) ; 19F NMR 
( CD , CN , 376 MHz ) : 8 - 79 . 3 ( s , 3F ) . 
Example 7 : Preparation of 5 - Benzyl - 1 , 3 - dimethyl 
[ 1 , 3 , 5 ] triazinan - 2 - one 
H3CV 3 N H?c , 1 CH , NCH , 
H3C 
4 - ( 4 - Iodobenzyl ) benzoic acid ( 3 . 8 mmol , 1 . 28 g , 1 . 0 eq . ) 
and N - hydroxysuccinimide ( 5 . 7 mmol , 0 . 66 g , 1 . 5 eq ) were 
dissolved in anhydrous CH , C1 , ( 20 mL ) . The mixture was 55 
cooled to 0° C . before N , N ' - dicyclohexylcarbodiimide 
( DCC , 5 . 7 mmol , 1 . 18 g , 1 . 5 eq ) dissolved in 10 mL CH2Cl2 
was added in a dropwise fashion . The mixture was stirred for 
12 hours at room temperature and filtered to remove pre 
cipitated N , N - dicyclohexylurea . The residue was washed 60 
with additional CH2Cl2 , and the combined filtrate was 
evaporated in vacuo . The residue was purified by column 
chromatography ( hexanes : ethyl acetate = 1 : 5 , Rf = 0 . 6 ) . 
Recrystallization with isopropanol or toluene / hexane 
afforded the title compound as a colorless solid ( 0 . 60 g , 65 
36 % ) . Recrystallization with isopropanol or toluene / hexane 
afforded the title compound as a colorless solid . ' H NMR 
BnNH2 
HCHO 82 % 
NH NH Z 
Bn 
Benzylamine ( 5 mL , 45 . 8 mmol ) , formaldehyde ( 37 % 
w / w solution , 7 . 5 mL , 91 . 6 mmol ) , and N , N - dimethylurea 
( 4 . 03 g , 45 . 8 mmol ) were combined in a reaction flask 
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equipped with a reflux condenser and heated to 100° C . Example 9 : Preparation of tert - butyl 
under an nitrogen atmosphere for 16 h . After it was cooled ( imino ( 1H - pyrazol - 1 - yl ) methyl ) carbamates 
to room temperature , the reaction mixture was quenched 
with water ( 50 mL ) and extracted with CH C12 ( 50 mLx2 ) . 
The combined organic layers were washed with brine , dried 5 
over anhydrous Na2SO4 , filtered , and concentrated . The 
residue was purified by flash chromatography ( silica gel , 
EtOH as eluent ) to give 5 - benzyl - 1 , 3 - dimethyl - [ 1 , 3 , 5 ] triazi 
nan - 2 - one ( 8 . 28 g , 82 % yield ) , isolated as a colorless solid . o Boc 
' H NMR ( 400 MHz , CDC13 ) 8 7 . 40 - 7 . 27 ( m , 5H ) , 4 . 12 ( s , N NH 
4H ) , 3 . 93 ( s , 2H ) , 2 . 86 ( s , 6H ) . 
Boc 
H3C IN H3C N H2 
Pdc 
Example 8 : Preparation of To a solution of di - tert - butyldicarbonate ( 13 . 4 g , 61 . 5 
1 , 3 - Dimethyl - [ 1 , 3 , 5 ] triazinan - 2 - one 15 mmol ) in acetone ( 45 mL ) were added 1H - pyrazole - 1 
carboxamidine hydrochloride ( 9 . 0 g , 61 . 5 mmol , 1 . 0 equiv . ) 
and 9 . 0 mL of water . K2CO3 ( 4 . 24 g , 30 . 6 mmol , 0 . 5 equiv . ) 
in H , O ( 12 . 0 mL ) was added dropwise for 30 min at room 
temperature . After 2 h , another portion of di - tert - butyldicar 
20 bonate ( 1 . 35 g , 6 mmol , 0 . 1 equiv . ) was added and the 
CH3 CH3 solution was stirred overnight . The acetone was removed 
94 % under reduced pressure and the resulting white solid was  / C dissolved in 30 . 0 mL of water , and allowed to stir at 0° C . 
for 30 min . The precipitated tert - butyl ( imino ( 1H - pyrazol 25 1 limothy 1 - yl ) methyl ) carbamate was collected by filtration , washed 
with water , washed with hexane , and dried in vacuo to 
provide the title compound as a colorless solid ( 11 . 37 g , 88 % 
5 - Benzyl - 1 , 3 - dimethyl - [ 1 , 3 , 5 ] triazinan - 2 - one ( 3 . 25 g , yield ) . ' H NMR ( CDC13 , 400 MHz ) : 8 9 . 06 ( brs , 1H ) , 8 . 45 
14 . 8 mmol ) was dissolved in EtOH ( 90 mL ) . To this solution - ( d , J = 3 . 2 Hz , 1H ) , 7 . 67 ( d , J = 0 . 8 Hz , 1H ) , 7 . 59 ( brs , 1H ) , 
was added Pd / C ( 10 % ) ( 500 mg ) , and the resulting mixture 6 . 39 ( dd , J = 2 . 8 , 1 . 6 Hz , 1H ) , 1 . 54 ( s , 9H ) . 
was heated to 65° C . under H2 ( 750 psi ) for 7 days . After the 
mixture was allowed to cool to room temperature , the Example 10 : Preparation of tert - butyl tert - butoxy suspension was filtered through Celite , and the eluent was 
concentrated by rotary evaporation to give 1 , 3 - dimethyl - [ 1 , 35 carbonyl ( ( ( tert - butoxycarbonyl ) imino ) ( 1H - pyrazol 1 - yl ) methyl ) carbamate 3 , 5 ] triazinan - 2 - one ( 1 . 80 g , 94 % yield ) , isolated as a color 
less solid . ' H NMR ( 400 MHz , CDC1z ) 8 4 . 14 ( s , 4H ) , 2 . 84 
( s , 6H ) , 2 . 52 ( brs , 1H ) . 
Bn 
kilik •HCI 
HN + ( Boc ) 20 SNH 
1 . 0 eq . 
0 . 5 eq . K2CO3 
acetone / water , r . t . 
1 . 1 eq . 
50 
Boc 
N NH 
55 b 
Boc 
CNSN . = N
2 . 1 eq . ( Boc ) 20 
10 mol % DMAP 
DCM , r . t . 4 - ( Dimethylamino ) pyridine ( 660 mg , 5 . 41 mmol ) was 
added to a solution of tert - butyl ( ( ( tert - butoxycarbonyl ) 
imino ) ( 1H - pyrazol - 1 - yl ) methyl ) carbamate ( 11 . 37 g , 54 . 1 
mmol , 1 . 0 equiv . ) in dichloromethane ( 60 mL ) . Di - tert 
butyldicarbonate ( 23 . 61 g , 108 . 2 mmol , 2 . 0 equiv . ) in THF 
7 . 5 mol % Mg ( CIO4 ) 2 ( 40 . 0 mL ) was slowly added over the course of 8 h using a 
THF , 50 - 60° C . syringe pump . The solution was stirred overnight at room 
temperature , before the solvents were removed in vacuo . 
The resulting colorless solid was stirred in dilute acetic acid 
60 solution ( 0 . 52 g , 8 . 66 mmol , acetic acid in 60 mL water ) . 
The precipitated tert - butyl tert - butoxycarbonyl ( ( ( tert - bu 
toxycarbonyl ) imino ) ( 1H - pyrazol - 1 - yl ) methyl ) carbamate 
was collected , washed with water , hexane , and dried in 
vacuo to yield a colorless solide ( 20 . 21 g , 91 % yield ) . ' H 
3 steps : 76 % 65 NMR ( CDC12 , 400 MHz ) : 8 8 . 20 ( d , J = 2 . 4 Hz , 1H ) , 7 . 69 ( d , 
CB?c J = 0 . 8 Hz , 1H ) , 6 . 45 ( dd , J = 2 . 8 , 1 . 6 Hz , 1H ) , 1 . 54 ( s , 9H ) , 
1 . 39 ( s , 18H ) . 
- goe B c
Boc 
??? 
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Example 11 : Preparation of tert - butyl ( ( ( tert - bu Example 13 : Preparation of tert - butyl ( ( ( tert - bu 
toxycarbonyl ) imino ) ( 1H - pyrazol - 1 - yl ) methyl ) car toxycarbonyl ) imino ) ( 3 , 5 - dimethyl - 4 - oxo - 1 , 3 , 5 - tri 
bamate azinan - 1 - yl ) methyl ) ( 3 - iodobenzyl ) carbamate 
Boc 
- Boc CH3 0 10 N 
N no 
Br 
Boc 
Boc BOCNO 
CH3 
The compound prepared in example 10 ( tert - butyl tert - 15 
butoxycarbonyl ( ( ( tert - butoxycarbonyl ) imino ) ( 1H - pyrazol Bu4NTI - , KOH 1 - yl ) methyl carbamate ) ( 20 . 21 g , 49 . 2 mmol , 1 . 0 equiv . ) , DCM / H2O Mg ( C1O4 ) 2 ( 823 mg , 3 . 69 mmol , 0 . 075 equiv . ) and THF ( 70 
mL ) were added to an over - dried , round bottomed flask , and 
the mixture was stirred at 50 - 60° C . for 5 hours . After 2 
completion of the reaction ( as monitored by TLC ) , the 
solvent was evaporated in vacuo and the residue was puri CH3 fied on silica gel chromatography ( EtOAc / hexane , 1 : 10 ) to CN CN CN 
61 % afford tert - butyl ( ( ( tert - butoxycarbonyl ) imino ) ( 1H - pyrazol - 75 
1 - yl ) methyl ) carbamates , isolated as a colorless solid ( 14 . 58 
g , 95 % yield ) . ' H NMR ( CDC13 , 400 MHz ) : 8 8 . 94 ( brs , 
1H ) , 8 . 31 ( d , J = 2 . 8 Hz , 1H ) , 7 . 63 ( d , J = 1 . 6 Hz , 1H ) , 6 . 42 CH3 
( dd , J = 2 . 8 , 1 . 6 Hz , 1H ) , 1 . 56 ( s , 9H ) , 1 . 50 ( s , 9H ) . 
30 A biphasic solution of tert - butyl ( ( ( tert - butoxycarbonyl ) 
imino ) ( 3 , 5 - dimethyl - 4 - oxo - 1 , 3 , 5 - triazinan - 1 - yl ) methyl ) car Example 12 : Preparation of tert - butyl ( ( ( tert - bu bamat ( 1 . 04 g , 2 . 8 mmol , 1 . 0 equiv . ) , tetrabutylammonium toxycarbonyl ) imino ) ( 3 , 5 - dimethyl - 4 - oxo - 1 , 3 , 5 - tri iodide ( 0 . 11 g , 0 . 3 mmol , 0 . 10 equiv . ) , and KOH ( 85 % , 0 . 37 azinan - 1 - yl ) methyl ) carbamate g , 5 . 6 mmol , 2 . 0 equiv . ) in a 1 . 4 / 1 . 0 mixture of CH , C1 , / H , O 
35 ( 24 . 0 mL ) was added dropwise with 3 - iodobenzyl bromide 
( 102 mg , 71 ul , 0 . 60 mmol , 1 . 2 equiv . ) in THF ( 4 . 0 mL ) over 
1 . 5 h . The reaction was stirred at room temperature for 12 
hours . At the completion of the reaction , the organic layer 
was separated and the aqueous layer was extracted with 
N THF 40 CH , C1 , ( 20 mLx2 ) . The combined organic extracts were 
washed with brine , dried over Na , SO . , filtered , and con 
centrated in vacuo . The residue was purified by flash chro 
??? matography ( silica gel , EtoAc as eluent ) to give the product ( 1 . 0 g , 61 % yield ) as a colorless solid . ' H NMR ( 400 MHz , 
45 CDC12 ) 8 7 . 71 ( s , 1H ) , 7 . 66 ( d , J = 7 . 9 Hz , 1H ) , 7 . 30 ( d , J = 7 . 8 
Hz , 1H ) , 7 . 07 ( t , J = 7 . 7 Hz , 1H ) , 4 . 46 ( brs , 6H ) , 2 . 74 ( brs , 
6H ) , 1 . 53 ( s , 9H ) , 1 . 47 ( s , 9H ) ; 13C NMR ( 100 MHz , CDC12 ) 
8 158 . 7 , 156 . 2 , 151 . 9 , 150 . 2 , 135 . 8 , 135 . 4 , 134 . 3 , 132 . 1 , NN 37 %  % 128 . 1 , 83 . 8 , 81 . 7 , 79 . 3 , 60 . 8 , 50 . 9 , 32 . 1 , 27 . 4 , 24 . 3 . 
Hot CH3 TOHTE 
Boc 
- N - - ºo0
Bocs 
??? CH3 
~ IZ 
50 50 Example 14 : Preparation of tert - butyl benzyl ( ( ( tert 
butoxycarbonyl ) imino ) ( 3 , 5 - dimethyl - 4 - oxo - 1 , 3 , 5 
triazinan - 1 - yl ) methyl ) carbamate CH3 
BOCN N 
Boc Boc , CN 
The compound prepared in example 11 ( tert - butyl ( ( ( tert - > 
butoxycarbonyl ) imino ) ( 1H - pyrazol - 1 - yl ) methyl ) carbam 
ate ) , ( 1 . 15 g , 3 . 7 mmol , 1 . 0 equiv . ) and 1 , 3 - dimethyl - [ 1 , 3 , 
5 ] triazinan - 2 - one ( 0 . 57 g , 4 . 4 mmol , 1 . 2 equiv . ) were CH3 dissolved in dry THF ( 15 mL ) under argon in an over - dried 60 CN  CNC 
flask . This solution was heated at 70° C . for 22 h . The 
mixture was allowed to cool to room temperature , the 
solvent was removed in vacuo , and the residue was purified 
by flash chromatography ( silica gel , EtoAc as eluent ) to CH3 
give the product as a colorless solid ( 0 . 51 g , 37 % yield ) . ' H 65 
NMR ( 400 MHz , CDC1z ) 8 10 . 5 ( brs , 1H ) , 4 . 70 ( s , 4H ) , 2 . 92 This model compound was prepared from benzyl bromide 
( s , 6H ) , 1 . 51 ( s , 9H ) , 1 . 50 ( s , 9H ) . using the procedure described in example 13 . ' H NMR ( 300 
44 
- continued 
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MHz , CDC13 ) 87 . 40 - 7 . 27 ( m , 5H ) , 4 . 43 ( brs , 6H ) , 2 . 67 ( brs , 
6H ) , 1 . 53 ( s , 9H ) , 1 . 46 ( s , 9H ) ; 13C NMR ( 75 MHz , CDC13 ) 
8 158 . 6 , 156 . 9 , 152 . 1 , 150 . 6 , 136 . 2 , 129 . 2 , 128 . 9 , 128 . 4 , HzC 
82 . 7 , 80 . 6 , 77 . 4 , 77 . 0 , 76 . 6 , 60 . 8 , 51 . 2 , 32 . 9 , 28 . 2 , 28 . 1 ; 
HRMS ( ESI ) Calcd for C23H35N30s : 461 . 2638 . Found : 
[ M + Na ] = 484 . 2536 . 
H3CM CHZ CH3 N N 
5 
BOC Boc 8 . 9 eq . KHF2 MeOH NaBoc 
10 10 Example 15 : Preparation of tert - butyl ( ( ( tert - bu toxycarbonyl ) imino ) ( 3 , 5 - dimethyl - 4 - oxo - 1 , 3 , 5 - tri 
azinan - 1 - yl ) methyl ) ( 3 - flurobenzyl ) carbamate 
i 
Boc 
N 
Boc 
BOCU CH3 N 
Boc 
NNN 
two steps : 61 % 
KF3B CH3 
45 
CH3 
This compound was prepared from 3 - fluorobenzyl bro 
mide using the procedure described in example 13 . ( 90 % ) . A flask charged with the iodoarene prepared in example 
' H NMR ( 400 MHz , CD2CN ) 8 7 . 40 - 7 . 32 ( m , 1H ) , 7 . 19 13 ( 1 . 20 g , 2 . 0 mmol , 1 . 0 equiv . ) , PdC12 ( PhCN ) 2 ( 39 mg , 7 . 03 ( m , 3H ) , 4 . 45 ( brs , 6H ) , 2 . 66 ( brs , 6H ) , 1 . 48 ( s , 9H ) , 301 0 . 10 mmol , 0 . 05 equiv . ) , bis ( diphenylphosphino ) ferrocene 1 . 43 ( s , 9H ) ; 13C NMR ( 100 MHz , CDC1z ) & 163 . 8 , 161 . 4 , ( 55 mg , 0 . 10 mmol , 0 . 05 equiv . ) , bispinacolatodiboron ( 1 . 02 158 . 8 , 156 . 4 , 152 . 0 , 150 . 6 , 138 . 9 , 138 . 8 , 130 . 6 , 130 . 5 , g , 4 . 0 mmol , 2 . 0 equiv . ) and KOAc 1 . 96 g , 20 . 0 mmol , 10 . 0 125 . 3 , 125 . 3 , 116 . 1 , 115 . 9 , 115 . 0 , 114 . 8 , 82 . 2 , 79 . 9 , 60 . 7 , equiv . ) , was flushed with nitrogen and degassed DMSO ( 20 50 . 4 , 32 . 1 , 27 . 3 , 27 . 3 . 35 mL ) was added . The mixture was heated at 80° C . and stirred 
for 12 hours , before the mixture was allowed to cool to room Example 16 : Preparation of potassium tert - butyl temperature . The mixture was extracted with ethyl acetate , 
( ( ( tert - butoxycarbonyl ) imino ) ( 3 , 5 - dimethyl - 4 - oxo - 1 , washed with water , dried over anhydrous sodium sulfate , 
3 , 5 - triazinan - 1 - yl ) methyl ) ( 3 - ( trifluoroboryl ) benzyl ) 20 and concentrated . The crude tert - butyl ( ( ( tert - butoxycarbo 
carbamate nyl ) imino ) ( 3 , 5 - dimethyl - 4 - oxo - 1 , 3 , 5 - triazinan - 1 - yl ) methyl ) 
( 3 - ( 4 , 4 , 5 , 5 - tetramethyl - 1 , 3 , 2 - dioxaborolan - 2 - yl ) benzyl ) car 
bamate was obtained as colorless solid ( 1 . 05 g ) after flash 
column chromatography ( silica gel , EtoAc as eluent to 
minimize the time of exposure to silica ) . ' H NMR ( 400 
CH3 MHz , acetone - do ) 8 7 . 76 ( s , 1H ) , 7 . 70 ( d , J = 7 . 4 Hz , 1H ) , 
7 . 51 ( d , J = 7 . 5 Hz , 1H ) , 7 . 38 ( t , J = 7 . 5 Hz , 1H ) , 4 . 50 ( brs , 
6H ) , 2 . 66 ( brs , 6H ) , 1 . 52 ( s , 9H ) , 1 . 47 ( s , 9H ) , 1 . 33 ( s , 12H ) ; 
50 13C NMR ( 100 MHz , acetone - do ) d 158 . 6 , 157 . 0 , 152 . 1 , 
150 . 6 , 138 . 5 , 138 . 1 , 137 . 4 , 130 . 6 , 128 . 4 , 94 . 5 , 83 . 1 , 80 . 7 , 
61 . 0 , 50 . 6 , 33 . 0 , 28 . 2 , 28 . 1 . 
The above pinacol ester ( 1 . 05 g ) was dissolved in MeOH 
55 ( 20 mL ) to which a solution of KHF2 ( aq ) ( 1 . 24 g , 15 . 9 
mmol , 4 . 5 M solution ) was added over the course of 1 . 0 h . 
This mixture was stirred for an additional hour before 
dichloromethane was added to generate a white precipitate . 
The precipitate was removed by filtration and washed with 
60 DCM . The mother liquor was concentrated to yield 1 . 22 g of 
5 mol % PhCl2 ( PhCN ) 2 crude product as white solid . This white solid was washed 5 mol % DPPF 
with hexane to obtain the pure trifluoroborate salt ( 0 . 69 g , 10 . 0 eq KOAC 
DMSO , 80º C . two steps 61 % ) . ' H NMR ( 500 MHz , CD2CN ) 8 7 . 38 ( d , 
65 J = 7 . 1 Hz , 1H ) , 7 . 35 ( s , 1H ) , 7 . 14 ( t , J = 7 . 5 Hz , 1H ) , 7 . 07 ( d , 
2 . 0 eq . J = 7 . 4 Hz , 1H ) , 4 . 91 ( brs , 1H ) , 4 . 46 ( brs , 3H ) , 4 . 01 ( brs , 2H ) , 
2 . 60 ( brs , 6H ) , 1 . 94 ( s , 9H ) , 1 . 44 ( s , 9H ) ; 13C NMR ( 100 
H3C N N 
+ 
Boc Boc 
1 . 0 eq . 
US 10 , 053 , 423 B2 
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MHz , CDC13 ) 8 158 . 9 , 156 . 6 , 152 . 0 , 151 . 1 , 133 . 9 , 132 . 3 , 
131 . 3 , 126 . 9 , 126 . 2 , 81 . 7 , 79 . 7 , 60 . 6 , 51 . 6 , 32 . 1 , 27 . 4 , 24 . 3 . 
- continued OMe 
Boc 
5 Example 17 : Preparation of 
1 - ( Diacetoxyiodo ) - 4 - methoxybenzene Boc BOCN CHZ  CN 
I 
CN À > 66 % > 66 % 
AcO . OAC 10 OTA E CH3 
45 % 
OMe 
NaBO3 - 4H20 In a N , charged glove box , 1 - ( diacetoxyiodo ) - 4 - methoxy CH3COOH 
40° C . 15 benzene ( 224 mg , 0 . 64 mmol , 1 . 0 equiv . ) was dissolved in 
7 . 0 mL of dry CH , CN . The solution was combined with a OMe 
solution of the trifluoroborate salt ( 397 mg , 0 . 70 mmol , 1 . 1 
4 - lodoanisole ( 2 . 34 g , 10 mmol ) was dissolved in 90 mL equiv . ) in 7 . 0 mL of dry CH3CN . Trimethylsilyl triflate ( 155 
of glacial acetic acid and the stirred solution was warmed to mg , 0 . 70 mmol , 1 . 1 mmol ) was added dropwise and the 
40 - 45° C . Sodium perborate tetrahydrate ( 15 . 4 g , 110 mmol ) mixture was allowed to stand at room temperature for 30 
was added in portions over the course of 3 h . After the 
addition was complete , the temperature of the reaction min . Saturated aqueous sodium acetate ( 20 mL ) was added 
mixture was maintained at 40° C . overnight before it was 25 and the mixture was extracted ( 3x20 mL ) with CH C12 . The 
allowed to cool to room temperature . The acetic acid ( ~ 30 combined organic extracts were dried over sodium sulfate 
mL ) was removed by distillation at reduced pressure . The and concentrated . This compound was dissolved in 1 mL remaining solution was treated with 100 mL of deionized 
water and the aqueous layer was extracted ( 40 mLx3 ) with acetonitrile / water ( 9 : 1 by volume ) solution and slowly 
dichloromethane . The combined organic fractions were 30 passed down an Amberlite IRA - 400 ion exchange column 
dried over sodium sulfate , and concentrated . The white solid ( triflate counterion ) . After removal of the solvents under was washed with hexane , then added 2 drops of glacial 
acetic acid and dried overnight in vacuo at 40° C . to give reduced pressure , the purified iodonium triflate product was 
1 . 60 g ( 45 % ) of 1 - ( diacetoxyiodo ) - 4 - methoxybenzene . ' H obtained by washing the colorless residue with pentane to 
NMR ( 400 MHz , CD2CN ) : d 8 . 06 ( d , J = 9 . 2 Hz , 2H ) , 7 . 05 35 remove any organic impurities The residue was recrystal ( d , J = 9 . 2 Hz , 2H ) , 3 . 86 ( s , 3H ) , 1 . 91 ( s , 6H ) . lized from dichloromethane to give 350 mg ( 66 % ) of the title 
iodonium triflate . ' H NMR ( 500 MHz , CD , CN ) 8 8 . 05 ( d , 
J = 8 . 0 Hz , 1H ) , 8 . 04 ( d , J = 9 . 2 Hz , 2H ) , 8 . 01 - 7 . 99 ( m , 1H ) , 
Example 18 : Preparation of ( 3 - ( ( N , N ' - bis ( tert - bu 7 . 69 ( d , J = 7 . 8 Hz , 1H ) , 7 . 50 ( t , J = 8 . 0 Hz , 1H ) , 7 . 04 ( d , J = 9 . 2 toxycarbonyl ) - 3 , 5 - dimethyl - 4 - oxo - 1 , 3 , 5 - triazinane Hz , 2H ) , 4 . 40 ( brs , 6H ) , 3 . 83 ( s , 3H ) , 2 . 60 ( brs , 6H ) , 1 . 48 ( s , 1 - carboximidamido ) methyl ) phenyl ) ( 4 - methoxyphe 
nyl ) iodonium triflate 9H ) , 1 . 43 ( s , 9H ) ; 1°F NMR ( CD CN , 376 MHz ) : 8 – 79 . 3 
45 ( s , 3F ) . 
40 
OAC OAC BFK 50 50 MeO 
N N . 
13 Y Boc 
TMSOTf , CD3CN 
Example 19 : Iodination of ( 3 - ( ( N , N - bis ( tert - bu 
toxycarbonyl ) - 3 , 5 - dimethyl - 4 - oxo - 1 , 3 , 5 - triazinane 
1 - carboximidamido ) methyl ) phenyl ) ( 4 - methoxyphe 
nyl ) iodonium triflate in benzene 
Boc 
OMe 
Boc Boc Boº - N 
Boc CH3 Boc CH3 B CN CN CN solvent removal ytes TMAI CD3CN 80° C . CoDo I . OTf CH3 CH3 
47 
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In a nitrogen atmosphere glove box , 0 . 020 mmol ( 17 mg ) ( ( ( tert - butoxycarbonyl ) imino ) ( 3 , 5 - dimethyl - 4 - oxo - 1 , 3 , 5 - tri 
of iodonium triflate was dissolved in 0 . 5 mL of dry acetoni azinan - 1 - yl ) methyl ) ( 3 - iodobenzyl ) carbamate were visible . 
trile - dz . A solution of 0 . 020 mmol ( 2 mg ) of TMAI in 0 . 2 mL This experiment indicated that polar solvents reduce the rate 
of dry acetonitrile - dz was added slowly . The mixture was of iodination significantly , even under stoichiometric con 
transferred into a J - Young NMR tube , sealed , and taken out en out 5 ditions . di 
of the glove box . The solvent was evaporated and the tube Example 21 : Iodination of ( 3 - ( ( N , N - bis ( tert - bu was taken back into the glove box . Dry benzene - do ( 0 . 6 mL ) toxycarbonyl ) - 3 , 5 - dimethyl - 4 - oxo - 1 , 3 , 5 - triazinane 
was added and transferred into a J - Young NMR tube , sealed , 1 - carboximidamido ) methyl ) - 2 , 6 - difluorophenyl ) ( 4 
and taken out of the glove box . The tube was wrapped in 10 methoxyphenyl ) iodonium triflate in CD2CN 
aluminum foil and placed in an 80° C . oil bath . After 1 hour , 
no remaining starting material was observable by ' H NMR 
spectroscopy , and the characteristic signals of tert - butyl 
( ( ( tert - butoxycarbonyl ) imino ) ( 3 , 5 - dimethyl - 4 - oxo - 1 , 3 , 5 - tri 
azinan - 1 - yl ) methyl ) ( 3 - iodobenzyl ) carbamates were visible . 13 
A CH? TMAI , 
Example 20 : Iodination of ( 3 - ( ( N , N ' - bis ( tert - bu CD3CN 
toxycarbonyl ) - 3 , 5 - dimethyl - 4 - oxo - 1 , 3 , 5 - triazinane 80° C . , NO 1 - carboximidamido ) methyl ) phenyl ) ( 4 - methoxyphe 
nyl ) iodonium triflate in CD2CN 
A - Boo 
Boca 
FAN CNN 
OTA 
1 . 5 h 
20 CH3 
Meo Meo ? Boc 
- Boo 
BOCN CH3 - Boc 25 
Boc BOCN 
OTf 
CH3 TMAI , NNN CD3CN 
80° C . , 
24 h N o CH3 24 h 30 30 F 
??? 
Boc CH3 35 trile - dz . A solutio 
NNN 
Meo In a nitrogen atmosphere glove box , 0 . 020 mmol ( 17 mg ) 
of iodonium triflate was dissolved in 0 . 5 mL of dry acetoni 
trile - dz . A solution of 0 . 020 mmol ( 2 mg ) of TMAI in 0 . 2 mL 
of dry acetonitrile - d , was added slowly . The mixture was 
transferred into a J - Young NMR tube , sealed , and taken out 
of the glove box , and the tube was wrapped in aluminum foil 
and placed in an 80° C . oil bath . The progress of the reaction 
CH3 40 was monitored by ' H NMR spectroscopy . After 90 minutes , 
no remaining starting material was observable by ' H NMR 
spectroscopy , and the characteristic signals of ( E ) - tert - butyl In a nitrogen atmosphere glove box , 0 . 020 mmol ( 17 mg ) ( ( ( tert - butoxycarbonyl ) imino ) ( 3 , 5 - dimethyl - 4 - oxo - 1 , 3 , 5 - tri 
of iodonium triflate was dissolved in 0 . 5 mL of dry acetoni azinan - 1 - yl ) methyl ) ( 2 , 4 - difluoro - 3 - iodobenzyl ) carbamate 
trile - dz . A solution of 0 . 020 mmol ( 2 mg ) of TMAI in 0 . 2 mL 45 were visible . This experiment indicated that the difluoro 
of dry acetonitrile - dz was added slowly . The mixture was substitution pattern significantly enhances the rate of iodi 
transferred into a J - Young NMR tube , sealed , and taken out nation significantly , even in polar solvents . 
of the glove box , and the tube was wrapped in aluminum foil 
and placed in an 80° C . oil bath . The progress of the reaction Example 22 : 1251 - Radioiodination of ( 3 - ( ( N , N ' - bis 
was monitored by ' H NMR spectroscopy . After 24 hours , no 50 ( tert - butoxycarbonyl ) - 3 , 5 - dimethyl - 4 - oxo - 1 , 3 , 5 
remaining starting material was observable by ' H NMR triazinane - 1 - carboximidamido ) methyl ) phenyl ) ( 4 
spectroscopy , and the characteristic signals of tert - butyl methoxyphenyl ) iodonium triflate in toluene 
OMe 
BOCN Boc 
???? CH3 Boc CH ; CN CNN NNCNCN B solvent removal = = = where Na * I 85° C . CH3CN * toluene OTf CH3 CH3 
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In a borosilicate vial , ( 3 - ( ( N , N - bis ( tert - butoxycarbonyl ) - present on the plate as Nal251 . However , an inventory of the 
3 , 5 - dimethyl - 4 - oxo - 1 , 3 , 5 - triazinane - 1 - carboximidamido ) activity showed that 90 % of the initial activity ( 270 uCi ) 
methyl ) phenyl ) ( 4 - methoxyphenyl ) iodonium triflate ( 15 mg ) remained in vial and was not incorporated into the product . 
in 200 uL of acetonitrile was treated with aqueous Na 251 ( 1 The total radiochemical yield of the product was 9 . 4 % . This 
uL sodium iodide solution , specific activity : ~ 17 Ci ( 629 5 example indicates that nonpolar solvents lead to relatively 
GBq ) / mg , 10 - M NaOH ( pH 8 - 11 ) , 300 uCi total activity ) poor incorporation of radioiodide if conventional , commer 
dissolved in 200 uL of acetonitrile . The solvent was removed cially available sodium salts are used . 
under reduced pressure . Toluene ( 250 uL ) was added and the 
mixture was heated at 85° C . for 30 minutes . The solution Example 23 : 1251 - Radioiodination of ( 3 - ( ( N , N ' - bis 
was removed from the vial and spotted on a silica gel TLC 10 ( tert - butoxycarbonyl ) - 3 , 5 - dimethyl - 4 - oxo - 1 , 3 , 5 
plate , along with authentic standard ( prepared in example triazinane - 1 - carboximidamido ) methyl ) phenyl ) ( 4 
13 ) . Elution of the product in 100 % ethyl acetate showed the methoxyphenyl ) iodonium triflate in 10 % 
fully 94 % of the activity was in the product , with 6 % still acetonitrile / toluene 
OME 
BOCN Boc 
Boc CHZ Boc CH ; TNCN CNC SNSNN solvent 
removal Na * I 
CH3CN 
85° C . 
10 % 
acetonitrile 
in toluene 
* 1 . 
N OTE 
CH3 
25 
35 os 
In a borosilicate vial , ( 3 - ( ( N , NP - bis ( tert - butoxycarbonyl ) 
3 , 5 - dimethyl - 4 - oxo - 1 , 3 , 5 - triazinane - 1 - carboximidamido ) 
methyl ) phenyl ) ( 4 - methoxyphenyl ) iodonium triflate ( 15 mg ) 
in 200 uL of acetonitrile was treated with aqueous Nal251 ( 1 
uL sodium iodide solution , specific activity : - 17 Ci ( 629 
GBq ) / mg , 10 - M NaOH ( pH 8 - 11 ) , 300 uCi total activity ) 
dissolved in 200 uL of acetonitrile . The solvent was removed 
under reduced pressure . A solution of acetonitrile ( 25 uL ) in 
toluene ( 225 uL ) was added and the mixture was heated at 
85° C . for 30 minutes . The solution was removed from the 
vial and spotted on a silica gel TLC plate , along with 
authentic standard ( prepared in example 13 ) . Elution of the 
product in 100 % ethyl acetate showed almost quantitative 
incorporation of the activity into the product with no 
40 residual Nal251 . An inventory of the activity showed almost 
no residual activity in the vial , and 291 uCi in the product 
solution . The total radiochemical yield of the product was 
97 % . This example indicates that a mixture incorporating a 
small amount of polar solvent in the nonpolar solvent leads 
45 to excellent incorporation of radioiodide with conventional , 
commercially available sodium salts . Moreover , the rate of 
reaction does not suffer significantly if a small amount of 
polar solvent is added . 
50 Example 24 : 1251 - Radioiodination of ( 3 - ( ( N , N ' - bis ( tert - butoxycarbonyl ) - 3 , 5 - dimethyl - 4 - oxo - 1 , 3 , 5 
triazinane - 1 - carboximidamido ) methyl ) phenyl ) ( 4 
methoxyphenyl ) iodonium triflate in 10 % 
acetonitrile / toluene Using a Small Amount of Pre 
cursor 
OMe 
Boc BOCN Boc 
Boc CH3 BOCU CH CN TNCN N TNCN solvent 
removal a wote Na * I CH3CN * 85° C . 10 % acetonitrile in toluene N OTE CH3 
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1 * 
tions . 
In a borosilicate vial , ( 3 - ( ( N , N ' - bis ( tert - butoxycarbonyl ) 
- continued 3 , 5 - dimethyl - 4 - oxo - 1 , 3 , 5 - triazinane - 1 - carboximidamido ) 
methyl ) phenyl ) ( 4 - methoxyphenyl ) iodonium triflate ( 1 mg ) N 
in 200 uL of acetonitrile was treated with aqueous Na1251 ( 1 CH ; 
uL sodium iodide solution , specific activity : - 17 Ci ( 629 5 CN CNCN HCI 
GBq ) / mg , 10 - 5M NaOH ( pH 8 - 11 ) , 300 uCi total activity ) 100° C . dissolved in 200 uL of acetonitrile . The solvent was removed N 
under reduced pressure . A solution of acetonitrile ( 25 uL ) in 
toluene ( 225 uL ) was added and the mixture was heated at CH3 85° C . for 30 minutes . The solution was removed from the 10 
?? vial and spotted on a silica gel TLC plate , along with 
authentic standard ( prepared in example 13 ) . Elution of the 
product in 100 % ethyl acetate showed 90 % incorporation of HN CNH , 
the activity into the product , 5 % residual Na1251 , and 5 % 
1251 - 4 - iodoanisole . An inventory of the activity showed 
almost no residual activity in the vial , and ~ 290 uCi in the 
product solution . The total radiochemical yield of the prod 
uct was 87 % . This example indicates that a reduced amount 
of substrate still provided good incorporation of the label , 
but that selectivity and yield are lower under these condi 20 Preparation of lodide Solution : 
Aqueous Nal241 was dissolved in 0 . 1M NaOH . 1 ul of 
Example 25 : Comparison of Iodination of Nal241 ( Na * I ; approximately 1 mCi ) was added to a reaction 
Diaryliodonium Salts with Fluorination , vial along with 1 ul of 1 . 0 M ACOH to prepare an acidic , 
Chlorination , and Bromination slightly buffered solution . Because the volume of water was 
25 so small , initial drying of the Na * I solution was not required . Each of the four bis ( 4 - methoxyphenyl ) iodonium halides ( For larger scale reactions that involve more water , an ( fluoride , chloride , bromide , iodide ) ( 10 mg ) was suspended azeotropic drying procedure with 400 ul of CH3CN was in C . D . , sealed in a J . Young NMR tube , and heated at 120° performed before the labeling step . ) C . for the times indicated : ( fluoride , 2 . 5 hours ; chloride , 5 Labeling : days ; bromide , 5 hours , iodide , 2 . 5 hours ) . The reactions 
were followed by ' H NMR spectroscopy and were deemed 30 ed 30 5 mg of the protected diaryliodonium precursor was 
completed when a homogeneous solution containing no dissolved in 400 ul of CH CN . The mixture was allowed to 
trace of the diaryliodonium salt starting material was stand for 10 minutes to make certain all of the crystalline 
obtained . Representative fH NMR spectra obtained at the substrate had dissolved . The dissolved precursor was added 
completion of reactions are show in FIG . 1 . to the reaction vial and the solution was evaporated with a 
Different reactivity modes are observed across the series 35 stream of dry argon at 90° C . ( approximately two minutes ) . 
of halides . Thermal decomposition of the diaryliodonium After the solvent was removed completely , 125 uL of 
fluoride in do - benzene gave mostly 4 - fluoroanisole and a CH , CN was added ( with shaking or stirring ) to dissolve the 
small amount of 3 - fluoroanisole . This side product probably salts . Toluene ( 125 uL ) was added and the solution was 
arises from a competing mechanism that involves a benzyne heated at 90° C . for 30 minutes . Silica TLC ( 100 % ethyl intermediate formed by ortho - proton extraction by the hard 10 40 acetate ) was performed to determine the labeling efficiency . base fluoride under these conditions . In contrast , chloride Intermediate Purification : and bromide reacted to provide the corresponding 4 - haloani A silica gel sep - pak plus was treated with hexanes ( 2x2 sole in quantitative yield ; no 3 - halo regioisomers were 
produced . This can be explained easily ; the basicity of mL ) such that hexanes remained on the sep - pak . ( The 
chloride and bromide are not high enough to promote sep - pak was not blown dry ) . The reaction mixture was 
benzyne formation by proton abstraction . In contrast to these 45 introduced to the sep - pak , followed by 3 mL of 1 : 1 toluene : 
three reactions , which appear to proceed through two acetonitrile . The eluent was collected and radio TLC analysis 
electron intermediates , the thermal decomposition of bis ( 4 ( Silica , 100 % ethyl acetate ) showed that almost all of the 
methoxyphenyl ) iodonium iodide produces 4 , 4 ' - dimethoxy - iodide salt was removed from the mixture . The solvents 
biphenyl , 1 , , and an unidentified arene product in addition to were evaporated ( under vacuum with a stream of argon at 
the 4 - iodoanisole . The biphenyl and I probably result from 50 90° C . ) . Full evaporation of the solvent from the 4 mL 
the formation of free radical intermediates . reactor vial took approximately 30 minutes . 
Deprotection : Example 26 : 1241 - Radioiodination General The residue in the reactor vial was dissolved in 200 ul of Procedure for the Preparation of 1241 - Labeled 6M HC1 , and heated at 100° C . for 10 minutes . The solution Benzylguanidine Derivatives 55 was allowed to cool for one minute and neutralized with 120 
ul of 10M NaOH . A reverse phase ( C18 ) sep pak was rinsed 
with ethanol ( 10 mL ) and water ( 10 mL ) and blown dry . The 
neutralized solution ( pH - 2 ) was passed through the sep pak 
and the sep pak was rinsed with 2 mL of water ( to elute any 
60 remaining salts ) and blown dry . Ethanol ( 0 . 8 mL ) was 
CH3 
CN CNN passed through the sep pak to elute the radiolabeled ben Na * I zylguanidine derivative . Ethanol was removed using a 
50 % stream of nitrogen before the material was purified by 
No acetonitrile HPLC . in toluene 
90° C . 65 Semipreparative HPLC of the Crude Reaction Mixture : The analysis and final HPLC was performed using an 
Alltech Econosphere C18 chromatography column ( 250x4 . 6 
?Me 
Boc Boº 
Boc 
OTE 
CH3 
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Boc 
N 
BOCN CH ; 
mm ) and the product was eluted with 50 % acetonitrile / 50 % 
20 mmol ammonium acetate at a flow rate of 1 . 5 mL per 
minute . 
Post HPLC Isolation : 
The collected fraction was diluted with 20 mL H2O and 
the radiolabeled product was trapped on a second C18 sep 
pak . The cartridge was rinsed with distilled water , blown 
dry , and the product was eluted in 0 . 8 mL of ethanol . 
Boc 
F CN CN CN HCI 
100° C . 
* I 
CH3 
10 F 
NH 
Example 27 : Preparation of 1241 - MIBG 
F  HN  CNH , 2
OMe 
BOCON 
BOC - CH3 
N 20 Na * I 
OTf 
50 % 
acetonitrile 
in toluene 
90° C . CH3 
1241 - 2 , 4 - difluoro - 3 - iodobenzylguanidine was prepared in 
80 + 6 % radiochemical yield ( n = 4 ) at the 1 - 2 mCi scale using 
the procedure outlined in Example 26 . Following isolation , 
the product was > 99 % chemically and radiochemically pure , 
25 as assayed by HPLC . Compared to MIBG , the difluorinated 
compound showed greater thermal stability to iodine loss 
during the deprotection reaction , so the yields of final 
product obtained was significantly higher . 
Boc 
Boca CH3 
N N N HCI 
100° C . 30 * Example 29 : Preparation of 
1241 - 4 - iodobenzylguanidine 
??3 
NH E
35 35 BOCN HN CNH , 
Boc CH2 CN CN CN Na * I 
40 50 % 
acetonitrile 
in toluene 
90° C . OTE CH3 
1241 - MIBG was prepared in 74 + 5 % radiochemical yield 
( n = 8 ) at the 1 - 2 mCi scale using the procedure outlined in 45 
Example 26 . The retention time for the labeled final product 
semipreparative HPLC purification was 7 . 3 minutes . Fol 
lowing isolation , the product was > 99 % chemically and 
radiochemically pure , as assayed by HPLC . 
50 
Boc Example 28 : Preparation of 1241 - 2 , 4 - difluoro - 3 
iodobenzylguanidine 
BOCN - CH2 N N 
OMe HCI 
100° C . 
Boc CH3 N . 
Boc CH3 FN N Na * I 
eri E N o OTE 
50 % 
acetonitrile 
in toluene 
90° C . Di CH3 F 
55 
- continued 
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Example 31 : Imaging and Biodistribution Study of 
124 - MIBG Prepared Using Two Methods NH 
HN ANH , 2
T * 
1241 - 4 - iodobenzylguanidineIBG was prepared in 62 : 6 % 
radiochemical yield ( n = 4 ) at the 1 - 2 mCi scale using the 
procedure outlined in Example 26 . Following isolation , the 
product was > 99 % chemically and radiochemically pure , as 
assayed by HPLC . 
Example 30 : Preparation of 1241 - 4 - iodo - 3 , 5 - difluo 
robenzylguanidine 
To determine whether the method of preparation of MIBG 
5 affected the biodistribution of the compound , high specific 
activity 1241 - MIBG was prepared using the diaryliodonium 
salt method ( Example 27 ) and the conventional stannylated 
resin precursor ; these compounds were imaged in rodent 
models . 
10 Eight male Sprague - Dawley rats were used for the study . 
Upon arrival at the laboratory , each animal was inspected , 
uniquely identified with the animal number written on their 
tails , and weighed . The animals were judged to be in good 
health and were immediately placed in acclimation . Animals 
15 were between 6 - 14 weeks of age and weighed 440 . 5 36 . 4 g . 
After a single intravenous dose of 1241 - MIBG prepared by 
diaryliodonium salt precursor , or 1241 - MIBG prepared with 
conventional method , Sprague - Dawley rats were given PET / 
CT scans at 1 , 4 , and 24 hours post injection of radiotracer . 
20 Biodistribution analysis was performed to quantify the 
amount of uptake in each animal ' s heart , liver , kidneys , 
thyroid , quadriceps muscle , and whole body as a function of 
time . Data is presented in units of uCi , uCi /mm3 , % ID , and 
% ID / g . The radiochemical purity of all compounds as 
25 assessed by HPLC was > 97 % within an hour of adminis 
tration . There was no noted qualitative or quantitative dif 
ference in the biodistribution of 1241 - MIBG prepared by 
diaryliodonium salt precursor and 1241 - MIBG prepared by a 
conventional method . 
Boc 
Boc BoC 
, CN CN CN Na * I 
o 
50 % 
acetonitrile 
in toluene 
90° C . OTf CH3 
30 
Other Embodiments 
It is to be understood that while the invention has been 
described in conjunction with the detailed description 
35 thereof , the foregoing description is intended to illustrate 
and not limit the scope of the invention , which is defined by 
the scope of the appended claims . Other aspects , advantages , 
and modifications are within the scope of the following 
claims . 
Boc 
Boc CH , N N 40 
What is claimed is : 
1 . A method for making a compound of Formula ( 1 ) : HCI 
100° C . 
CH3 
45 
Ar > _ * I 
wherein : 
Ar is an aryl or heteroaryl ring system ; and 
I * is a radioactive isotope of iodine ; 
wherein the radioactive isotope of iodine has a specific 
activity of at least about 1 mCi / mg ; 
the method comprising : ( a ) reacting a mixture comprising a compound M * I , 
wherein M is a counter cation , and compound of 
Formula ( 2 ) : 
50 
NH NH 
HN CNH , 55 
2 
Arl . 
Ap2 
* 60 
1241 - 4 - iodo - 3 , 5 - difluorobenzylguanidine was prepared in 
70 7 % radiochemical yield ( n = 4 ) at the 1 - 2 mCi scale using 
the procedure outlined in Example 26 . Following isolation , 65 
the product was > 99 % chemically and radiochemically pure , 
as assayed by HPLC . 
wherein : 
Ar is an aryl or heteroaryl ring system that is electron 
rich as compared to Ar ; 
Y is a leaving group ; and 
Ar2 is as defined above ; and ( b ) heating the reaction mixture from step ( a ) . 
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- continued 2 . The method of claim 1 , wherein the reaction mixture in 
step ( a ) further comprises a solvent . 
3 . The method of claim 2 , wherein the solvent is removed 
from the reaction mixture prior to step ( b ) . 
4 . The method of claim 1 , wherein the reaction mixture in 5 
step ( b ) further comprises a solvent . 
5 . The method of claim 1 , wherein Art — H is more easily 
oxidized than benzene . 
6 . The method of claim 1 , wherein Arl is substituted with 
at least one substituent having a Hammett o , value of less 
than zero . 
7 . The method of claim 6 , wherein the substituent is 
selected from the group consisting of : ( C1 - C10 Jalkyl , 
- C - C10 ) haloalkyl , ( C2 - C10 ) alkenyl , ( C2 - C10 ) alkynyl , 
- O - ( C1 - C10 ) alkyl , - C ( O ) - 0 – ( C1 - C10 ) alkyl , aryl , and heteroaryl . 15 
8 . The method of claim 1 , wherein the radioactive isotope 
of iodine is selected from the group consisting of : 1231 , 1241 , 
1251 , and 1311 . 
9 . The method of claim 1 , wherein Arl is : 
Qay 
N 
NN 
Br 
N? 
NNN 
å 
so 
R ? PI ortar apar Br Br å R4 
30 
Z 
- 
N TO 
wherein : 
R1 , R² , RS , R4 , and R $ are independently selected from the 
group consisting of : H , ( C , - C10 ) alkyl , ( C , - C10 ) 
haloalkyl , ( ( C2 - C10 ) alkenyl , ( C2 - C10 ) alkynyl , - 0 – ( C2 - C10 ) alkyl , - C ( O ) - 0 – ( C - C10 ) alkyl , aryl , and 
heteroaryl , or two or more of R " , R ? , R3 , R4 , and RS z 
come together to form a fused aryl or heteroaryl ring 
system . 
10 . The method claim 1 , wherein AP is selected from the group consisting of : a phenylalanine derivative , tyrosine 
derivative , tryptophan derivative , histidine derivative , and 
an estradiol derivative . 
11 . The method of claim 1 , wherein AP is selected from 
the group consisting of : 
V? 
40 NIX 
- 0
45 ??????? 50 
Z 
Z - 55 
X -
F N o pro 
Orte Orlar pro 60 V† N N N Na Z X - 65 
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– Boc F dormi N N Boc F Br 
??? 10 
NANON 
N N 
o 
Boc 15 
- 
– Boc 
N Z 
20 
X - NANON 
Boc 
25 
Boc 
N N 
30 Boc 
Boc 
35 1 
NN 
- 
Boc wherein each X is independently a protecting group . 
12 . The method of claim 11 , wherein Ar ’ is selected from 40 
the group consisting of : F Boc 
??? 
N 
45 
Boc 
NNCN F 
Boc Bo ??? 
50 V ore on 
orta : p Boc N Z - Boc Z N 1 55 - Boc F 
Boc NBoc 
N N 
13 . The method of claim 1 , wherein Y is selected from the 
60 group consisting of : triflate , mesylate , nonaflate , hexaflate , 
tosylate , nosylate , brosylate , perfluoroalkyl sulfonate , tetra 
phenylborate , hexafluorophosphate , trifluoroacetate , tetra 
fluoroborate , perchlorate , perfluoroalkylcarboxylate , and 
chloride . 
65 14 . The method of claim 1 , wherein M is selected from the 
group consisting of : lithium , potassium , sodium , cesium , 
complexes of lithium , sodium , potassium , or cesium with 
Boc 
Br 
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- continued cryptands or crown ethers , tetrasubstituted ammonium cat ions , and phosphonium cations . 
15 . The method of claim 1 , wherein the compound of 
Formula ( 2 ) is selected from the group consisting of : E non 5 
EN Z 
- 
X 
N N Lagir porte Os 
V 
2 
v 
X -
Bri N o 
süga 
Z -
F y Br 
Net 
N ja XZ 
Poep world beloop 
obdan qora 
- 3)
uus 
F 9 V? 
Z N N 
F 
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V 
N Z Art Laos X - 10 Tfo 
OTf 
N Z aorta dar 
K 
. . aan N? OTf 
N N 
F 
OT 
ö F 
??? 
N Z 
X -apshotos 
3 . Ob 
É 
TfO 
F wherein each Y is independently a leaving group as 50 defined above ; and 
each X is independently a protecting group . 
16 . The method of claim 15 , wherein the compound of 
Formula ( 2 ) is selected from the group consisting of : 55 
OTE F 
60 
TO Dolg : amount 65 OTE F 
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Boc 0c Boc 
` N SNS SNSNS ) 
Boc Boc 
F 
OTf 10 OTf 
voc 15 Arc 
NS 
Boc Boc So 20 
OTf OTE 
Boe 
Boc OG 
25 
SN SN SN 
NN 
Boc 
Bog F SF 
Br " 
30 
OTf 
OTf 
- 
? 
??? 
- 
35 
Boc Boc 
N SN SN NSN 
? 
- 
?? 
= 40 Boc Boc 
OTf Br OTf E F 
Boc 45 Moe ? ? 17 . The method of claim 1 , wherein the compound of Formula ( 1 ) is selected from the group consisting of : " N SNS ) 
Boc 50 
OTf 
55 
Boc 
6 ) 
SN SNT I 
Boc 
65 
OTf ( 
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- - 
? NN . 
* 
F ? 
N ??? NN * ? 
- ???? ??? ?? ? F ???? ?? - - - 
- 
. ?? 
???? ??? 
} - 
Z N 
Z * N * 
F ??? F * 
M 
- 4 
2 or * - - 
F ? - 8 
Z 
55 
wherein each X is independently a protecting group . 
18 . The method of claim 17 , wherein the compound of 
Formula ( 1 ) is selected from the group consisting of : 
Boc 
66 ) 
* N ???? NN - Boc 65 Br 
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Boc 
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- continued 
NBoc 
VN N N 
Boc Boc 
* N 
F 
Boc  ??? N 
N 
Boc ??? Br F 
* Boc Boc 
N N CN CN or Boc Boc - Br F Boc N 
19 . A method for making a compound of Formula ( 1 ) 
NCN CN 
Boc 30 
Ar2 _ * I 1 
wherein : 
Ar ” is an aryl or heteroaryl ring system ; and 
* I is a radioactive isotope of iodine ; 
wherein the radioactive isotope of iodine has a specific 
activity of at least about 1 mCi / mg ; 
the method comprising heating a compound of Formula 
( 3 ) : 
Boc 
- Boo A 
35 
N N 
Boc 
N TO 
40 
– Boc 
Art A 
CN CNN or 45 ??? F wherein : Arl is an aryl or heteroaryl ring system that is electron rich as compared to Ar ? ; and Ar2 is as defined above . * 
* * * * * 
